STARPHARMA HOLDINGS ORDINARY (SPL) Short Interest
STARPHARMA HOLDINGS ORDINARY (ASX:SPL) had 0.11% of shares reported as short positions as of 16 July 2026, representing 455,495 shares. STARPHARMA HOLDINGS ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Starpharma Holdings
Starpharma Holdings is an Australian biotechnology company focused on developing dendrimer technology for pharmaceutical and life science applications. Their proprietary dendrimer platform is used to improve drug delivery, enhance drug efficacy, and create new pharmaceutical products. The company's market position is built on its innovative technology and partnerships with pharmaceutical companies.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4SPL intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Starpharma Holdings
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss SPL
Start a research thread or post the first pulse update